Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

Slate Medicines has secured a $130m Series A financing round aimed at advancing anti-PACAP migraine therapies.

NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated CLD and GMP manufacturing.

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...

Beren Therapeutics has received the US FDA acceptance to review its NDA for adrabetadex, an investigational therapy targeting intracellular cholesterol trafficking for infantile-onset NPC.

The US Food and Drug Administration (FDA) has issued more information to sponsors regarding its “plausible mechanism pathway”, a new framework to spur the development of therapies for ultra-rare ...

Gilead is now waiting upon the FDA’s approval of anito-cel, Arcellx’s lead candidate, slated for December 2026.

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) to enhance pharmaceutical education and research ...

J&J's Pennsylvania cell therapy manufacturing site is one of four US-based facilities the company plans to build over the ...

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

Following a difficult year that saw Ixchiq’s license suspended in the US, Valneva is pinning hopes on upcoming pipeline ...